Multiple Myeloma Patients Treated at Higher-volume Facilities Have Better Outcomes, Study Finds
Patients treated for multiple myeloma at facilities that see a…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read morePatients treated for multiple myeloma at facilities that see a…
Longer duration of maintenance therapy with Revlimid (lenalidomide)…
Inhibiting a key protein in the tumor microenvironment using…
Amgen announced that its RANKL inhibitor, Xgeva (denosumab) met…
A three-drug therapy combination consisting of Darzalex (…
Understanding how multiple myeloma develops and responds to therapies…